Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

By J. Barker, D. Weisdorf, T. Defor, B. Blazar, P. Mcglave, Jeffrey S. Miller, C. Verfaillie, J. Wagner. Blood, 2005

892 citations recorded by the source corpus.

Subfields: Hematology, Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/9e0a0410e978947c8c0141eaa05cf3daf640a79b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. I. Borrello

Citations in the corpus

• HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. (2008, background): “For adult hematologic malignancies patients who lack suitably matched related or unrelated donors, encouraging outcomes have also been obtained with transplantation of HLAhaploidentical related stem cells after myeloablative conditioning [10,57] or with transplantation of 1 or 2 umbilical cord blood”
• Notch-mediated Expansion of Human Cord Blood Progenitor Cells Capable of Rapid Myeloid Reconstitution (2010, result): “We observed substantially enhanced rates of myeloid engraftment, with a decrease in the median time to neutrophil recovery by more than 1 week, as compared to published times to neutrophil recovery after infusion of two unmanipulated unit”